EGFR-Positive Head and Neck Squamous Cell Carcinoma research hub

A study to evaluate the safety, tolerability and distribution of TB0010 in head and neck squamous cell carcinoma

This early study is looking at a new medicine called TB0010 for people with a certain type of head and neck cancer. Doctors want to see if the medicine is safe, how well people tolerate it, and how it moves through the body.